MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.
Issue link: https://medesthetics.epubxp.com/i/813546
60 MAY/JUNE 2017 | Med Esthetics PERSONA L PERCEPTION OF SU BM ENTA L FAT Allergan has released the results of a new survey on personal perception of double chins that it conducted in conjunction with its Kybella injectable product for submental fat. The survey included 1,996 U.S.-based respondents (1,025 women and 971 men) between the ages of 18 and 65. Nearly half (45%) of respondents felt people noticed the area under their chins and 47% reported being bothered by the ap- pearance of the area underneath their chins; 49% said the area under their chins negatively impacts their appearance. Women were more likely than men to be bothered by the appearance of their chins (55% vs. 40%). The survey asked respondents if their feelings about the ap- pearance of their chins affected their behavior. Thirty fi ve percent reported that they shy away from photos and avoid video chats or conference calls, and 29% of men have grown beards to hide their double chins. ASPS STATISTICS SHOW I NCR EASED DEM A N D A N D H IGH LIGHT N EW TR EN DS New data released by the American Society of Plastic Surgeons (ASPS) show a 3% growth in cosmetic procedures over the last year. There were 17.1 million surgical and minimally invasive cos- metic procedures performed in the U.S. in 2016, and facelifts— which dropped from the top fi ve most popular surgical procedures in 2015—made a comeback in 2016. Demand for fat grafting, fat reduction and skin tightening all increased: • Minimally invasive cosmetic fat injections increased 13% • Buttock augmentation using fat grafting increased 26% • Breast augmentation using fat grafting increased 72% • Injection-based procedures that target fat pockets in specifi c areas increased 18% • Fat reduction procedures that freeze fat increased 5% • Skin tightening procedures increased 5% Cosmetic surgical procedures grew at a slightly higher rate than minimally invasive procedures (4% vs. 3%). Of the nearly 1.8 million cosmetic surgical procedures performed in 2016, the top fi ve were: 1. Breast augmentation (290,467 procedures, up 4%) 2. Liposuction (235,237 procedures, up 6%) 3. Rhinoplasty (223,018 procedures, up 2%) 4. Eyelid surgery (209,020 procedures, up 2%) 5. Facelifts (131,106 procedures, up 4%) Among the 15.5 million minimally invasive cosmetic procedures performed in 2016, the top fi ve were: 1. Botulinum toxin type A (7 million procedures, up 4%) 2. Soft tissue fi llers (2.6 million procedures, up 2%) 3. Chemical peels (1.36 million procedures, up 4%) 4. Laser hair removal (1.1 million procedures, down 1%) 5. Microdermabrasion (775,000 procedures, down 3%) For the fi rst time the statistics included data on labiaplasty, which the ASPS began tracking in 2015. Demand for the surgery increased by 39% in 2016, with more than 12,000 procedures performed. SCITON LAU NCH ES BBL PR ECEPTORSH I P TOU R Sciton, a manufacturer of medical laser and light systems, has an nounced new dates for its 2017 Bright Lights Big City Tour in sup- port of its BroadBand Light (BBL) device. Patrick Bitter Jr., MD, will be hosting full-day preceptorships on the Sciton BBL. He will share his insights and techniques on treating vascular lesions, pigment, acne and erythema with the BBL. Topics will include: an overview of BroadBand Light treatment; Fotofacial treatments; treating darker skin types with the BBL; BBL and Halo fractional combination treat- ments and more. The tour will be coming to the following cities: May 20, Atlanta September 9, Seattle September 23, Washington, D.C. October 21, Minneapolis November 10, Dallas Physicians can register online at sciton.com/bbltour A A D A N NOU NCES N EW PR ESI DENT Detroit-based dermatologist Henry W. Lim, MD, FA AD, is the new president of the American Academy of Dermatology (A AD). He assumed his role at the conclusion of the Academy's 2017 Annual Meeting in Orlando, Florida. He will hold offi ce for one year. Dr. Lim is chair emeritus of the department of dermatology and senior vice president for academic affairs at Henry Ford Health System in Detroit. He previously served as the A AD's vice president; as a member of its board of directors; and as former chair of its Re- search Agenda Committee, Council on Science and Research, and Scientifi c Assembly Committee. Dr. Lim is also past president of the American Dermatological Association and the American Board of Dermatology. He has authored more than 400 articles and has served as the editor or co-editor of seven textbooks. "A top priority will be positioning the specialty to meet the chal- lenges of today's complex healthcare environment," said Dr. Lim. "Additional key areas of focus will be on enhancing the quality of patient care and promoting diversity in medicine." R EPLICEL MOV ES FORWA R D W ITH DER M A L I NJ ECTOR PROTOTY PE RepliCel Life Sciences has signed agreements with two European fi rms—Austrian manufacturer AMI and Art of Technology ("AoT"), based in Zurich—to manufacture and test the company's motorized RCI-02 dermal injector prototypes. The RCI-02 injector was designed to improve the delivery of injectables in order to minimize the risks and uncertainties of injection outcomes. The device offers programmable depth and volume; a built-in Peltier element for pre-injection anesthesia; and NEWS & EVENTS Henry W. Lim, MD, FAAD